Aegis Analytical Corp., a leading provider of Manufacturing Process Intelligence software, announced today that Genzyme, one of the world’s leading biotechnology companies, has deployed Aegis’ Discoverant data management and analytics solution at its Geel, Belgium, manufacturing facility.

The operation at Geel is a state-of-the-art cell culture production facility for therapeutic proteins and is among the largest bio-manufacturing sites in Europe.

“With the implementation of Discoverant, Genzyme will enhance its production capabilities and support the commercial release of its unique therapies to market,” said Robert M. Di Scipio, Aegis president and CEO.

Discoverant is an off-the-shelf product specifically designed to help manage pharmaceutical and biopharmaceutical manufacturing processes. It enables on-demand access to, and correlation of, data in disparate product data sources, such as paper records, manufacturing execution systems (MES), laboratory information management systems (LIMS), Oracle databases and data warehouses in one validatable environment. Discoverant helps provide process understanding which increases process predictability, reduces process start-up risks, improves product quality, decreases cycle time and assures compliance within good manufacturing practices (GMP) and Food and Drug Administration (FDA)-regulated production and packaging environments.

“In the life science industry, where process predictability and time to value are paramount, we see companies successfully using Discoverant to accelerate time to market by enabling the technology transfer from development into commercial manufacturing,” commented Hussain Mooraj, AMR Research’s vice president, healthcare & life sciences.